FY2025 · ended Dec 31, 2025 · Revenue $6.07B, +11.5% YoY · Filed Feb 25, 2026
Edwards Lifesciences Corporation (EW) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $6.1 billion and net income of $1.1 billion. Free cash flow was $1.3 billion. As of Sep 30, 2026 it held $4.9 billion in cash and investments and $704.5 million in total debt.
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- EW (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Irvine, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1099800
- Former names
- CVG CONTROLLED INC (until Jan 21, 2000)
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
- Cadre Holdings, Inc. CDRE
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $6.1B | $5.4B | $5.0B | $4.5B | $5.2B |
| Operating income | $1.3B | $1.4B | $1.3B | $1.5B | $1.7B |
| Net income | $1.1B | $4.2B | $1.4B | — | — |
| Diluted EPS | $1.83 | $6.97 | $2.30 | $2.44 | $2.38 |
| Operating cash flow | $1.6B | $542.3M | $895.8M | $1.2B | $1.7B |
| Free cash flow | $1.3B | $289.9M | $642.8M | $973.6M | $1.4B |
| Total assets | $13.7B | $13.1B | $9.4B | $8.3B | $8.5B |
| Total liabilities | $3.4B | $3.0B | $2.6B | $2.5B | $2.7B |
| Stockholders' equity | $10.3B | $10.0B | $6.7B | $5.8B | $5.8B |
| Cash and investments | $4.5B | $4.3B | $2.2B | $2.5B | $3.3B |
| Total debt | $705.4M | $700.0M | $685.1M | $691.3M | $690.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 28, 2026 | Aug 25, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 23, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 8, 2026 | May 7, 2026 |
All 1003 Edwards Lifesciences Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.